Comments
Loading...

Blueprint Medicines Stock Guidance

BPMCNASDAQ
Logo brought to you by Benzinga Data
$88.72
At close: Mar 21, 4:00 PM EDT
$88.72
0.000.00%
After Hours: Mar 21, 4:00 PM EDT

Blueprint Medicines Stock Guidance | NASDAQ:BPMC | Benzinga

Blueprint Medicines issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
01/05/2023BPMC
Blueprint Medicines
FY2022———$200.00M$200.00M$199.69MGet Alert
11/01/2022BPMC
Blueprint Medicines
FY2022———$200.00M$200.00M$191.21MGet Alert
08/02/2022BPMC
Blueprint Medicines
FY2022———$180.00M$200.00M$194.85MGet Alert
05/03/2022BPMC
Blueprint Medicines
FY2022———$180.00M$200.00M$192.34MGet Alert
02/16/2022BPMC
Blueprint Medicines
FY2022———$180.00M$200.00M$210.91MGet Alert
01/10/2022BPMC
Blueprint Medicines
FY2021———$180.00M$180.00M$173.16MGet Alert
10/28/2021BPMC
Blueprint Medicines
FY2021———$170.00M$180.00M$148.37MGet Alert

FAQ

Q

What is the most recent guidance for Blueprint Medicines (BPMC)?

A

There have been no specific sales or earnings guidance reported for Blueprint Medicines in recent months.

Browse guidance and forecast on all stocks.

People Also Watch